A Longitudinal Observational Study of the Natural History and Management of Patients With HCC

Purpose

TARGET-HCC is a longitudinal, observational study of patients being managed for HCC in usual clinical practice. TARGET-HCC will create a research registry of participants with HCC within academic and community real-world practices in order to assess the safety and effectiveness of the entire spectrum of current and future therapies across diverse populations.

Condition

  • Hepatocellular Cancer

Eligibility

Eligible Ages
Over 18 Years
Eligible Genders
All
Accepts Healthy Volunteers
No

Inclusion Criteria

  1. Male or female patients, age ≥18 years 2. Patients with a histological/cytological or radiological diagnosis of HCC (mixed HCC cholangiocarcinoma may be included; patients who are candidates for surgical and non-surgical treatment, as well as those being followed without specific HCC therapy may be included)

Exclusion Criteria

  1. Inability to provide written informed consent

Study Design

Phase
Study Type
Observational [Patient Registry]
Observational Model
Cohort
Time Perspective
Prospective

Recruiting Locations

Piedmont Cancer Institute
Atlanta, Georgia 30318
Contact:
Katie Adams
678-298-3238
kadams@piedmontcancerinstitute.com

University of Pennsylvania
Philadelphia, Pennsylvania 19104
Contact:
Laura Tague
215-614-0285
Laura.Tague@pennmedicine.upenn.edu

More Details

NCT ID
NCT02954094
Status
Recruiting
Sponsor
Target PharmaSolutions, Inc.

Study Contact

Stephanie Harrison
sharrison@targetrwe.com